Foto di copertina di OPIS
OPIS

OPIS

Servizi di ricerca

Desio, Monza Brianza 80.295 follower

A Science Driven Biotech Focused CRO

Chi siamo

OPIS was founded in 1998 by medical doctors from the Pharma Industry and is a global clinical CRO with 27 years of experience in a wide range of therapeutic areas. OPIS provides full-service, 360° clinical trial support from study concept creation and protocol development to full project execution, study data handling and up to study closure, analysis, and reporting. We manage Phase I-IV, interventional, non-interventional and medical device studies on an international level. In addition, OPIS also manages pre- and post-marketing clinical investigations for medical and diagnostic devices, nutraceuticals, and food supplement studies. Our qualified, fully trained, and dedicated staff have managed more than 1500 studies. OPIS’s strength lies in its people and its specialized teams who assist clients from A-Z with medical writing, scientific and statistical consultancy for trial design and skilled teams of operational staff that ensure high-quality project execution, with global coverage. Our mission is to increase the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas, including oncology, cardiology, dermatology, endocrinology, gastroenterology, gene therapy, hematology, genetic diseases, hepatology, immunology, infectious diseases, musculoskeletal, dietary supplements, metabolism and nutrition disorders, nephrology, neurology, onco-hematology, ophthalmology, respiratory diseases, rare diseases, urogenital disorders and vaccines. OPIS is committed to continuous growth and expansion, and currently we have affiliates in 18 countries around the world. For more information, visit www.opisresearch.com For Employment and Careers, visit www.opisresearch.com/opis-career/

Sito Web
www.opisresearch.com
Settore
Servizi di ricerca
Dimensioni dell’azienda
201-500 dipendenti
Sede principale
Desio, Monza Brianza
Tipo
Società privata non quotata
Data di fondazione
1998
Settori di competenza
Clinical Research, CRO, Clinical Development, Early phase trials, Post market studies, Observational research, Real world evidence studies, investigator initiated trials, medical device clinical investigations, nutraceutical studies, medical affairs and medical writing, Regulatory, Trials Start-Up, Data Management, Pharmacovigilance, Quality Assurance, e-Clinical Platform, Project Control, Statistical Analysis and Consultancy, Staudy Management and Monitoring, Preclinical and Drug Development Consultancy, Medical Monitoring, Medical Feasibility e Other Services

Località

Dipendenti presso OPIS

Aggiornamenti

  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    🔹 OPIS is thrilled to announce our participation in the 17th Annual SCOPE Summit for Clinical Ops Executives! Join us at the Rosen Shingle Creek Resort in Orlando, Florida, from February 2 to 5, where over 1,200 companies from 30 countries will gather to explore the future of clinical research. This year’s agenda includes key topics such as: 🔹 Protocol Optimization   🔹 Patient-Centric Trial Design   🔹 Site Engagement & Recruitment   🔹 Generative AI in Trials   🔹 Small Biopharma Strategies   🔹 RBQM and ClinTech Investment  We look forward to engaging in high-impact discussions and connecting with leaders across the clinical trial ecosystem. Reach out and schedule a meeting with us in Orlando. See you there!

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    🔹 Korea Night JPM 2026 On January 14, the #OPIS team had the pleasure of being invited to attend Korea Night at The Howard SF, an exclusive event spotlighting some of the most dynamic and innovative biotech companies from Korea. This high-impact networking opportunity was a great moment to connect with key players shaping the future of healthcare and explore new global collaborations. Thank you to the organizers and everyone we had the chance to meet, we look forward to building impactful partnerships across borders!

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    🔹 Strategic Partnership Announcement with GCCL We’re pleased to share that OPIS Research CRO has signed a strategic Memorandum of Understanding (MOU) with GCCL, a global clinical trial specimen analysis organization, during the 2026 J.P. Morgan Healthcare Conference in San Francisco. This collaboration responds to the growing demand for customized, multi-country clinical trial solutions, driven by increasingly complex regulatory environments across Europe and the Asia-Pacific (APAC) region. Through this partnership, OPIS and GCCL will collaborate on: 🔹 Global clinical trial service cooperation 🔹 Joint marketing and project support 🔹 Creation of new international business opportunities By combining OPIS’s global CRO network and 27 years of clinical expertise with GCCL’s GCLP-certified clinical trial analysis capabilities, the partnership aims to deliver integrated, efficient, and tailored clinical trial solutions for drug developers worldwide. We extend our sincere thanks to Mr. Cho Kwan-gu, CEO of GCCL, for his leadership and collaboration in making this strategic partnership possible. Click the link to read the full article: https://lnkd.in/dixa87JD

    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    🔹 That’s a wrap for Biotech Showcase 2026! A big thank you to everyone who stopped by Booth T-16 at the Hilton San Francisco Union Square to meet the OPIS team.   It was a pleasure connecting with so many biotech innovators and partners during #JPMWeek2026. We’re grateful for the engaging conversations and look forward to building impactful partnerships. Let’s keep it going! Reach out and schedule an appointment.

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    🔹 Yesterday was an absolute blast for the last day of RESI 2026!   Our delegates Meredith Lewko and Karen Lewis have been manning the booth at the San Francisco Marriott Marquis and having a great time interacting with industry peers sharing about OPIS services that can better help your clinical trials.    We want to thank everyone who took the time to meet and speak with our delegates. Your engagement makes all the difference.   Reach out to schedule a meeting and discuss the future of clinical trials with us!

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    🔹 During #JPMWeek2026, our #OPIS delegates are not only attending the main conferences but are also engaging in unique activities surrounding the event.   Kelley Emmons, Director of Clinical Development, took part in Sweat Equity 5K in a 5 AM run for JPM attendees Monday morning, showing commitment beyond the conference halls.   Meanwhile, Changsook Park, our Business Development Director, attended the ABDD SUMMIT 2026 at Stanford, expanding global insights and connections.   It’s inspiring to see our #OPIS team fully embracing every opportunity to connect, contribute, and collaborate during JPM Week festivities.   Drop by at the OPIS Booth T-16 for the last day of Biotech Showcase, and don’t miss the chance to schedule a meeting on the PartneringOne platform by January 14. See you there!

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    🔹 Today is the last day for Biotech Showcase 2026.   We've already had an amazing couple of days connecting and interacting with global biopharma leaders and investors during JPM Week 2026 wherein we were able to share how OPIS can help you in your clinical trial journey. There is still time to visit us at Booth T-16 and meet our delegates: 🔹 Giovanni Trolese, Vice President  🔹 Changsook Park, Business Development Director 🔹 Pilar Bescós Vilaseca, Clinical Operations Manager 🔹 Kelley Emmons, Director of Clinical Development   Let’s make the most of this final day and explore new opportunities for collaboration. See you there!

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    Day 1 of RESI JPM 2026 Conference & BioPartnering!   🔹 #OPIS is thrilled to be taking part in these two events happening at the Marriott Marquis.    Come visit our delegates and learn how OPIS can support your clinical development journey with tailored CRO solutions and scientific excellence.   🔹 Elena Ravasi, Senior Director of Clinical Development 🔹 Meredith Lewko, Director of Clinical Development 🔹 Karen Lewis, Clinical Operations Manager 🔹 Claude Morgan, Business Development Associate Connect with us through the official platform for RESI - Hello Partnering & BioPartnering Platform! Let’s make the most of the last day at RESI JPM 2026 later today. See you there!

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    Day 1 at Biotech Showcase 2026!   🔹 #OPIS is excited to be onsite at the Hilton San Francisco Union Square for the Biotech Showcase 2026!   You can find us at #Booth T-16, ready to connect with biotech innovators, investors, and global partners. Stop by and meet our delegates: 🔹 Giovanni Trolese, Vice President  🔹 Changsook Park, Business Development Director 🔹 Pilar Bescós Vilaseca, Clinical Operations Manager 🔹 Kelley Emmons, Director of Clinical Development Don’t miss your chance to connect! Schedule a meeting with us on the PartneringOne Platform by Wednesday, January 14 and let’s explore how we can create impactful partnerships together. We’re excited to share ideas, collaborate, and build meaningful opportunities. See you there!

    • Nessuna descrizione alternativa per questa immagine
    • Nessuna descrizione alternativa per questa immagine
  • Visualizza la pagina dell’organizzazione OPIS

    80.295 follower

    In one week, industry leaders from across healthcare and life sciences will gather to share insights, outlooks, and plans for the year ahead. 🔹 Our #OPIS Business Development team will be participating in multiple conferences during JPM Week and looks forward to connecting throughout the week. If you’re attending and would like to schedule time for a brief conversation, feel free to reach out via the respective platforms or stop by our booths. We’re always open to discussing how teams are navigating clinical development in an evolving landscape. See you in San Francisco!

Pagine simili

Sfoglia le offerte di lavoro